{"name":"Perle Bioscience, Inc.","slug":"perle-bioscience-inc","ticker":"","exchange":"","domain":"","description":"Perle Bioscience, Inc. is a biopharmaceutical company focused on developing innovative drug formulations. Despite having two discontinued drug candidates, the company continues to explore new opportunities in the pharmaceutical space.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPd0NCQ0dDajR3YnVOeFVRTGtBS1l6dlFGN3NteGZ4dm93OTlCYTBVX2dtb3ZYaDJOX0JadEV6WXFXdkJQNW1udHRnbjNVRkFIczFnN0NRU3J0MXRJRXVWV2JWMjRWQUpZY09Cc2ZsQXlxVEZKaWFHUWp5RE16VTNPeGpBRDB6V2VWOWRkZ2NvN3RZZjQ?oc=5","date":"2024-03-12","type":"pipeline","source":"BioSpace","summary":"Merck Bets Potential $1B on Pearl Bio’s Genomically Recoded Organisms - BioSpace","headline":"Merck Bets Potential $1B on Pearl Bio’s Genomically Recoded Organisms","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}